drugset / Trial / NCT06046196
Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
This clinical trial aims to assess the non-inferiority of Sarpogrelate SR 300mg once daily compared to Sarpogrelate 100mg three times daily in patients having intermittent claudication among chronic artery occlusive disease, based on changes in the Ankle-Brachial Index (ABI).
Timeline
- Start
- 2020-11-18
- Primary completion
- 2023-03-09
- Completion
- 2023-03-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sarpogrelate | Small molecule | 100 mg | — |
| Subject | Sarpogrelate | Small molecule | 300 mg | — |